Lung cancer treatment options are exploding! Targeted agent use in neoadjuvant and adjuvant sphere is a big focus. Does Alectinib work in adjuvant setting and can osimertinib find a role neoadjuvantly? Truly a fascinating time! #lungcancer #MedEd

open.spotify.com/episode/3HrJSI…

#osim #osim 40mg
#osim ertinib #奥西替尼
#Osimertinib is used to treat lung cancer. #cancermedicine
Website: medicine-international.com

#osim #osim 40mg
#osim ertinib #奥西替尼
#Osimertinib is used to treat lung cancer. #cancermedicine
Website: medicine-international.com

Not one, not 2, but 3 lung cancer plenaries at #ASCO24 ! Early telemed pall care, the LAURA trial of consolidation osimertinib after CRT for stage 3 EGFR non small cell lung cancer & the ADRIATIC trial of consolidation immunotherapy after CRT for small cell lung cancer! #lcsm

Cơ Chế Hoạt Động của Osimertinib
Xem thêm: kingfucoidan.vn/thuoc-osimerti…
#Thuốc_osimertinib , #Tác_dụng_của_thuốc_osimertinib , #Liều_dùng_thuốc_osimertinib , #kingfucoidan

コンパクトパネルはOsimertinibのコンパニオン診断薬ですよ

Osimertinibが使えない検査なんて誰も出しません笑

🫁 Osimertinib + LT for 🧠mets in EGFRm NSCLC.
🅰️ 121 patients with EGFRm (19del or L858R)
☢️ 45 in Osi+LT vs 76 in Osi alone
✅ OS: Osi+LT group NR vs. Osi alone 31.2 m
🔺 HR for OS: 0.37
🧠 HR for CNS-PFS 0.36

OncoDaily
OncoAlert

👉🏼 doi.org/10.1016/j.lung…

- Tagrisso
- Osimertinib
- NSCLC treatment
- Lung cancer medication
- EGFR mutation inhibitor
- #Tagrisso
- #Osimertinib
- #LungCancer
- #NSCLC
- #CancerTreatment
- #EGFRmutation
- #FightCancer
- #Healthcare
- #Oncology
- #CancerAwareness

New cancer clinical trial: High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib ift.tt/u7sl5yw

New in Translational #CancerBiology from the April 15 issue:
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant #LungCancer in Permissive Cellular Contexts, by Bomiao Hu, Dr. Katerina Politi et al.
bit.ly/3WltzzP
Yale Pathology Yale Cancer Center

②EGFR ex20 insはOsimertinibですらほぼ効かず、EGFRの中でも治療に難渋してきた遺伝子変異です。Amivantamabは有効性を示しており、待望の薬剤です(まだ承認されていませんが)。Amivantamabの承認も、オンコマインが診断薬になるのも時間の問題だと思います。

#奥西替尼 #Osimertinib
#欧思美 #奥希替尼
#osiinda #ositab
#OSITAB #Tagrisso
#t790m #Osiem
#甲磺酸奥希替尼
#Osiem #osinib #tagrix
#targeteddrug #靶向药物
#genericdrug #中国 #Bangladesh
WeChat : drug-international / lifesaving-medicine
website : medicine-international.com

🧐Hide and Seek🥇 #ASCO24
🔥LAURA
🎯Osimertinib as consolidation after CRT in EGFRm Locally advanced NSCLC
astrazeneca.com/media-centre/p…
🔥ADRIATIC
🎯Durvalumab as consolidation after CRT in LS-SCLC
astrazeneca.com/media-centre/p…
#LCSM OncoAlert ASCO

Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer

nature.com/articles/s1227…

Osimertinib with platinum-based #chemotherapy has received #FDAapproval for patients with locally advanced or metastatic #NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. ow.ly/rihx50R715M

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (OSTARA)
clinicaltrials.gov/study/NCT05801…
✅Sponsor：AstraZeneca

#Jenpharpharmaceuticals
#Tasso
#Tasso 80mg
#Osimertinib
#奥希替尼
#Cancermedicine #Bangladesh

BUY ONLINE
WeChat : drug-international / lifesaving-medicine Website : medicine-international.com

New cancer clinical trial: JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations ift.tt/wVL54hn

Osimertinib re-administration for CNS metastases in NSCLC positive for EGFR activating mut
bit.ly/44bY2T0
✅No apparent correlation was observed between the interval from the end of the initial Osi to re-administration of Osi and the PFS with regard to CNS lesions.

Ruoshuang Han, Haoyue Guo, Jinpeng Shi and colleagues investigate the impact on osimertinib-resistant non-small cell lung cancer of combination therapies.
Read the full study here: bmcmedicine.biomedcentral.com/articles/10.11…